The initiative comes after the Africa CDC warned that the outbreak remains uncontrolled, with more than 7,400 cases and 3,500 deaths reported. Ervebo was utilized during previous Ebola outbreaks, and health officials are now determining if the vaccine provides adequate immunity against the specific strain currently circulating in the region.
Wednesday, October 21, 2026
Story
DR Congo Tests Ervebo Ebola Vaccine on 20,000 Workers for Current Strain
World31 days ago
The Democratic Republic of Congo launched trials of the Ervebo vaccine for medical personnel stationed at the center of the nation's current Ebola crisis. The experimental rollout targets 20,000 frontline workers to protect those most exposed to the virus. This effort focuses on establishing a protective barrier for health providers in the highest-risk zones of the epidemic.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.